Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein

被引:137
作者
Jiang, HB
Nucifora, FC
Ross, CA
DeFranco, DB [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Neurosci, Pittsburgh, PA 15261 USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat & Neurosci,Lab Mol Neurobiol, Program Cellular & Mol Med, Baltimore, MD 21205 USA
关键词
D O I
10.1093/hmg/ddg002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's Disease belongs to the CAG repeat family of neurodegenerative diseases and is characterized by the presence of an expanded polyglutamine (polyQ) repeat in the huntingtin (htt) gene product. PolyQ-expanded htt accumulates within large aggregates that are found in various subcellular compartments, but are more often localized within the nucleus. It has been suggested that the sequestration of proteins essential to cell viability may be one mechanism that accounts for toxicity generated by polyd-expanded proteins. Nuclear inclusions containing polyQ-expanded htt recruit the transcriptional cofactor, CREB-binding protein (CBP). PolyQ toxicity appears to involve alterations of gene transcription and reduced neuronal cell viability. In the HT22 hippocampal cell line, we find that toxicity within individual cells induced by polyQ-expanded htt, as revealed by a TUNEL assay, is associated with the localization of the mutant htt within either nuclear or perinuclear aggregates. However, in addition to CBP recruitment, we show here that CBP ubiquitylation and degradation can be selectively enhanced by polyQ-expanded htt. Thus, selected substrates may be directed to the ubiquitin/proteasome-dependent protein degradation pathway in response to polyQ-expanded htt within the nucleus.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 66 条
[1]   Cytoplasmic localization and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch [J].
Becker, M ;
Martin, E ;
Schneikert, J ;
Krug, HF ;
Cato, ACB .
JOURNAL OF CELL BIOLOGY, 2000, 149 (02) :255-262
[2]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[3]  
Browne SE, 1999, BRAIN PATHOL, V9, P147
[4]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[5]  
Bush KT, 1997, J BIOL CHEM, V272, P9086
[6]  
Chai YH, 1999, J NEUROSCI, V19, P10338
[7]  
Chan HM, 2001, J CELL SCI, V114, P2363
[8]   Expressed luciferase viability assay (ELVA) for the measurement of cell growth and viability [J].
Coombe, DR ;
Nakhoul, AM ;
Stevenson, SM ;
Peroni, SE ;
Sanderson, CJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1998, 215 (1-2) :145-150
[9]   Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture [J].
Cooper, JK ;
Schilling, G ;
Peters, MF ;
Herring, WJ ;
Sharp, AH ;
Kaminsky, Z ;
Masone, J ;
Khan, FA ;
Delanoy, M ;
Borchelt, DR ;
Dawson, VL ;
Dawson, TM ;
Ross, CA .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :783-790
[10]   Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice [J].
Cummings, CJ ;
Reinstein, E ;
Sun, YL ;
Antalffy, B ;
Jiang, YH ;
Ciechanover, A ;
Orr, HT ;
Beaudet, AL ;
Zoghbi, HY .
NEURON, 1999, 24 (04) :879-892